MedTrace Logo

Neonatal and Maternal Effects of Buprenorphine and Methadone

NCT03024736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-11-21

No results posted yet for this study

Summary

In this retrospective chart review, the investigators plan to analyze the effects of buprenorphine compared to methadone in opioid-maintained pregnant women. The investigators will evaluate both maternal and neonatal outcomes, with a primary outcome of infant hospital length of stay. The investigators will evaluate patients receiving care in a single setting.

Conditions

  • Opioid-maintained Pregnant Women

Interventions

OTHER

buprenorphin

if buprenorphine has better neonatal outcomes compared to methadone in the treatment of opioid-maintained pregnant women

Sponsors & Collaborators

  • St. Louis University

    lead OTHER

Principal Investigators

  • Jaye Shyken, MD · St. Louis University

Eligibility

Min Age
13 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-09-30
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03024736 on ClinicalTrials.gov